References
- Stava CJ, Jimenez C, Hu MI, et al. Skeletal sequelae of cancer and cancer treatment. J Cancer Surviv. 2009;3(2):75–88.
- Dushyanthen S, Cossigny DA, Quan GM. The osteoblastic and osteoclastic interactions in spinal metastases secondary to prostate cancer. Cancer Growth Metastasis. 2013;6:61–80.
- Batteux B, Bennis Y, Bodeau S, et al. Associations between osteoporosis and drug exposure: a post-marketing study of the world health organization pharmacovigilance database (VigiBase®). Bone. 2021;153:116137.
- Pfeilschifter J, Diel IJ. Osteoporosis due to cancer treatment: pathogenesis and management. J Clin Oncol. 2000;18(7):1570–1593.
- Shapiro CL, Van Poznak C, Lacchetti C, et al. Management of osteoporosis in survivors of adult cancers with nonmetastatic disease: ASCO clinical practice guideline. J Clin Oncol. 2019;37(31):2916–2946.
- Coleman R, Hadji P, Body JJ, et al. Bone health in cancer: ESMO clinical practice guidelines. Ann Oncol. 2020;31(12):1650–1663.
- McCloskey E, Rathi J, Heijmans S, et al. The osteoporosis treatment gap in patients at risk of fracture in European primary care: a multi-country cross-sectional observational study. Osteoporos Int. 2021;32(2):251–259.
- Curtis JR, Carbone L, Cheng H, et al. Longitudinal trends in use of bone mass measurement among older Americans, 1999–2005. J Bone Miner Res. 2008;23(7):1061–1067.
- Baum T, Muller D, Dobritz M, et al. Converted lumbar BMD values derived from sagittal reformations of contrast-enhanced MDCT predict incidental osteoporotic vertebral fractures. Calcif Tissue Int. 2012;90(6):481–487.
- Keaveny TM, Clarke BL, Cosman F, et al. Biomechanical computed tomography analysis (BCT) for clinical assessment of osteoporosis. Osteoporos Int. 2020;31(6):1025–1048.
- Loffler MT, Sollmann N, Mei K, et al. X-ray-based quantitative osteoporosis imaging at the spine. Osteoporos Int. 2020;31(2):233–250.
- Roski F, Hammel J, Mei K, et al. Opportunistic osteoporosis screening: contrast-enhanced dual-layer spectral CT provides accurate measurements of vertebral bone mineral density. Eur Radiol. 2021;31(5):3147–3155.
- Svendsen P, Shekhrajka N, Nielsen KL, et al. R-CHOP(-like) treatment of diffuse large B-cell lymphoma significantly reduces CT-assessed vertebral bone density: a single center study of 111 patients. Leuk Lymphoma. 2017;58(5):1105–1113.
- Poeschel V, Held G, Ziepert M, et al. Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial. Lancet. 2019;394(10216):2271–2281.
- Leonhardt Y, May P, Gordijenko O, et al. Opportunistic QCT bone mineral density measurements predicting osteoporotic fractures: a use case in a prospective clinical cohort. Front Endocrinol. 2020;11:586352.